Learning curve of lung dose optimization in intensity-modulated radiotherapy for locally advanced non-small cell lung cancer
- PMID: 37466172
- PMCID: PMC10493474
- DOI: 10.1111/1759-7714.15046
Learning curve of lung dose optimization in intensity-modulated radiotherapy for locally advanced non-small cell lung cancer
Abstract
Background: Intensity-modulated radiotherapy (IMRT) has been increasingly used for patients with locally advanced non-small cell lung cancer (LA-NSCLC). However, there are some barriers to implementing IMRT for LA-NSCLC, including the complexity of treatment plan optimization. This study aimed to evaluate the learning curve of lung dose optimization in IMRT for LA-NSCLC and identify the factors that affect the degree of achievement of lung dose optimization.
Methods: We retrospectively evaluated 40 consecutive patients with LA-NSCLC who received concurrent chemoradiotherapy at our institution. These 40 patients were divided into two groups: 20 initially treated patients (earlier group) and 20 subsequently treated patients (later group). Patient and tumor characteristics were compared between the two groups. The dose-volume parameter ratio between the actually delivered IMRT plan and the simulated three-dimensional conformal radiotherapy plan was also compared between the two groups to determine the learning curve of lung dose optimization.
Results: The dose-volume parameter ratio for lung volume to receive more than 5 Gy (lung V5) and mean lung dose (MLD) significantly decreased in later groups. The spread of the beam path and insufficient optimization of dose coverage of planning target volume (PTV) might cause poor control of lung V5, MLD.
Conclusions: A learning curve for lung dose optimization was observed with the accumulation of experience. Appropriate techniques, such as restricting the beam path and ensuring dose coverage of PTV during the optimization process, are essential to control lung dose in IMRT for LA-NSCLC.
Keywords: intensity-modulated radiotherapy; learning curve; lung cancer; lung dose; optimization.
© 2023 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


Similar articles
-
Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and conventional intensity-modulated radiotherapy in locally advanced non-small-cell lung cancer: a retrospective study.Radiat Oncol. 2019 Jun 13;14(1):106. doi: 10.1186/s13014-019-1259-3. Radiat Oncol. 2019. PMID: 31196118 Free PMC article.
-
Intensity modulated radiotherapy of non-small-cell lung cancer incorporating SPECT ventilation imaging.Med Phys. 2010 Apr;37(4):1863-72. doi: 10.1118/1.3358128. Med Phys. 2010. PMID: 20443508
-
Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: a dose-escalation planning study.Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):306-13. doi: 10.1016/j.ijrobp.2010.06.025. Epub 2010 Oct 1. Int J Radiat Oncol Biol Phys. 2011. PMID: 20888706
-
Intensity-modulated radiotherapy, not 3 dimensional conformal, is the preferred technique for treating locally advanced lung cancer.Semin Radiat Oncol. 2015 Apr;25(2):110-6. doi: 10.1016/j.semradonc.2014.11.002. Epub 2014 Nov 15. Semin Radiat Oncol. 2015. PMID: 25771415 Free PMC article. Review.
-
Pitfalls and Challenges to Consider before Setting up a Lung Cancer Intensity-modulated Radiotherapy Service: A Review of the Reported Clinical Experience.Clin Oncol (R Coll Radiol). 2016 Mar;28(3):185-97. doi: 10.1016/j.clon.2015.08.002. Epub 2015 Aug 29. Clin Oncol (R Coll Radiol). 2016. PMID: 26329504 Review.
Cited by
-
Effects of Institutional Experience on Plan Quality in Stereotactic Radiotherapy Using HyperArc for Brain Metastases.In Vivo. 2025 Jan-Feb;39(1):210-217. doi: 10.21873/invivo.13819. In Vivo. 2025. PMID: 39740907 Free PMC article.
-
Treatment time and learning curve analysis of 1.5 T MR-Linac workflows led by radiation oncologists or therapists.Clin Transl Radiat Oncol. 2024 Dec 14;51:100901. doi: 10.1016/j.ctro.2024.100901. eCollection 2025 Mar. Clin Transl Radiat Oncol. 2024. PMID: 39867726 Free PMC article.
References
-
- Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, et al. Non‐small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20:497–530. - PubMed
-
- Staffurth J. Radiotherapy development board. A review of the clinical evidence for intensity‐modulated radiotherapy. Clin Oncol (R Coll Radiol). 2010;22:643–657. - PubMed
-
- Fleckenstein J, Kremp K, Kremp S, Palm J, Rübe C. IMRT and 3D conformal radiotherapy with or without elective nodal irradiation in locally advanced NSCLC: a direct comparison of PET‐based treatment planning. Strahlenther Onkol. 2016;192:75–82. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical